What is a Mycotic Aneurysm?
A mycotic aneurysm is an infected aneurysm of a blood vessel caused by microbial invasion of the arterial wall, most commonly by bacteria (despite the misleading term "mycotic" which historically referred to its mushroom-like appearance rather than fungal etiology). 1
Historical Context and Terminology
The term "mycotic aneurysm" was coined by William Osler in 1885 to describe the mushroom-like appearance of infected aneurysms associated with bacterial endocarditis, not because they were caused by fungi. 2, 3, 4 This creates ongoing confusion since "mycotic" by definition suggests fungal origin, yet the vast majority are bacterial. 3 True fungal aneurysms are exceedingly rare, with only seven cases reported between 1966-1999. 3
It is critical to distinguish mycotic aneurysms from syphilitic aneurysms, which develop through a completely different chronic inflammatory mechanism 10-25 years after initial spirochetal infection and predominantly affect the ascending thoracic aorta as fusiform aneurysms. 5, 6 Syphilitic aneurysms are not acute infectious processes like true mycotic aneurysms. 6
Epidemiology and Location
Mycotic aneurysms are rare, accounting for only 0.7% to 4.5% of all aortic aneurysms and approximately 0.6% of aneurysms overall in Western countries. 1, 2 The distribution by location is: 1
- Abdominal aorta: ~70% (predominantly suprarenal, unlike atherosclerotic aneurysms which are 85% infrarenal)
- Thoracic aorta: ~30%
- Visceral arteries: <1%
- Intracranial arteries: 0.7-6.5% of all intracranial aneurysms, most commonly in the middle cerebral artery (44% of cases) 5
Men predominate over women by 3:1, with average age >65 years, and strong associations with cigarette smoking and diabetes mellitus. 1
Pathophysiology: Five Key Mechanisms
The American Heart Association describes five distinct mechanisms for mycotic aneurysm development: 1
Infected atherosclerotic plaque: The normal aortic intima resists infection, but damaged endothelium from atherosclerotic plaques or ulcers can be colonized during bacteremia, leading to infected atherosclerotic aneurysm formation. 1
Vasa vasorum infection: Bacteremic or contiguous spread to the vasa vasorum proceeds inward toward the vessel wall, causing localized infection with wall thinning and aneurysm development. 1
Contiguous spread: Infection extends from gastrointestinal sources (especially Salmonella gastroenteritis) or vertebral osteomyelitis, creating primary abdominal aortic mycotic aneurysms or secondarily infecting preexisting atherosclerotic aneurysms. 1
Congenital abnormalities: Endothelial damage from cystic necrosis or coarctation makes vessels susceptible to infection from bacteremia or contiguous spread. 1
Cardiac surgery-related: Mycotic aneurysms in the sinus of Valsalva or aortic arch develop following reconstructive surgery, infective endocarditis, or prosthetic valve endocarditis. 1
Microbiology: Evolving Spectrum
The microbiological profile has shifted dramatically in recent years: 1
- Staphylococci (S. aureus and coagulase-negative): Now the most common cause, accounting for 50-60% of cases 1
- Gram-negative bacilli: Previously dominant, now 30-40% of cases 1
- Salmonella species (especially nontyphoidal strains like S. enteritidis and S. choleraesuis): More common in Asia, with special predilection for vascular tissue; 25% of patients ≥50 years with Salmonella bacteremia have endovascular infection 1
- Other gram-negatives including Arizona species, Pseudomonas aeruginosa 1, 2
- Less common pathogens: Listeria monocytogenes, Mycobacterium tuberculosis (via vertebral osteomyelitis erosion), Streptococcus pneumoniae, anaerobes 1, 2
- Fungi: Candida and Aspergillus species are rare but reported 1, 3
Clinical Presentation: Nonspecific but Critical Features
The classic triad of fever, pain, and pulsatile abdominal mass is actually uncommon. 1, 7 More realistic presentations include: 1
- Fever: Present in ≥70% of intra-abdominal cases (uncommon in uninfected atherosclerotic aneurysms) 1
- Back pain: 65-90% of cases (less common in uninfected aneurysms) 1
- Intrathoracic mycotic aneurysms: Fever, chest and interscapular pain, findings of infective endocarditis or prosthetic valve infection 1
- Visceral artery involvement:
Catastrophic Complication: Rupture
Complete or contained rupture occurs in 50-75% of patients, with rupture sites including: 1
- Retroperitoneal/peritoneal space (50%)
- Duodenum (12%)
- Pleural cavity (10%)
- Esophagus, mediastinum, or pericardium (3-5%)
Impending or contained rupture presents with severe pain, hemodynamic instability, or sudden catastrophic rupture with shock and high mortality. 1
Diagnostic Approach
CT angiography (CTA) is the initial imaging procedure of choice, allowing rapid examination in potentially unstable patients requiring urgent surgical intervention. 1 CTA defines: 1
- Precise location and vascular anatomy
- Detection of impending rupture
- Associated complications
- Serial monitoring capability
Key imaging characteristics distinguishing mycotic from atherosclerotic aneurysms: 5
- Saccular, lobular, or irregular morphology (vs. fusiform)
- Minimal to absent calcification
- Periaortic soft tissue stranding/inflammatory changes
- Rapid enlargement on serial imaging
Laboratory findings are nonspecific: 1
- Leukocytosis (65-85% of cases)
- Elevated inflammatory markers (ESR, CRP in 75-80%)
- Blood cultures positive in 50-90% of cases 5
Critical Clinical Pitfalls
Do not confuse with inflammatory abdominal aortic aneurysms (5-10% of all AAAs), which occur in older men with smoking/diabetes history but fever is less common. 1
Suspect aortoenteric fistula and mycotic aneurysm in patients with recent or remote AAA repair; up to 4% develop aortoenteric fistulae. 1
In renal transplant recipients, consider mycotic aneurysm related to perinephric infections, particularly in the external iliac artery. 1
Lumbar spine osteomyelitis is present in up to one-third of patients with Salmonella-caused aortic mycotic aneurysms. 1